Lopinavir and Ritonavir Tablet shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting 2026-07-24 · last update 2026-07-24
Manufacturers: AbbVie Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-0522-60) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/24/2026 Updated 07/24/2026 Discontinued 07/24/2026 |
| Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-3008-60) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/24/2026 Updated 07/24/2026 Discontinued 07/24/2026 |
| Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-4014-12) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/24/2026 Updated 07/24/2026 Discontinued 07/24/2026 |
| Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-6799-22) | AbbVie Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 07/24/2026 Updated 07/24/2026 Discontinued 07/24/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)